TYRA241220P30000
- 0.00
- 0.000.00%
TYRA BIOSCIENCES, INC. Newsroom
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $29
Tyra Biosciences Analyst Ratings
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $30
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $33
TD Cowen Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating
TD Cowen Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $32
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $32
Tyra Biosciences Price Target Maintained With a $28.00/Share by Wedbush
Tyra Biosciences Analyst Ratings
TD Cowen Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $33
Piper Sandler Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $33
BofA Securities Upgrades TYRA BIOSCIENCES, INC.(TYRA.US) to Buy Rating, Announces Target Price $31
Jefferies Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $31
BofA Securities Upgrades TYRA BIOSCIENCES, INC.(TYRA.US) to Buy Rating, Raises Target Price to $31
Tyra Biosciences Upgraded to Buy From Neutral at BofA
Piper Sandler Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $33
Tyra Biosciences Is Maintained at Buy by HC Wainwright & Co.
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $30